Yale Podnos
Chief Medical Officer · Starling Oncology, Inc.
- 2024
- Jul 17, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yale Podnos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jorey Chernett - $2.69M in STLN purchases and sales in the last 12 months
- Brad Hively - $2.00M in STLN purchases and sales in the last 12 months
- Mohit Kaushal - $335K in STLN purchases and sales in the last 12 months
- Mark L. Pacala - $200K in STLN purchases and sales in the last 12 months
- Robert Ross Carter - $879 in STLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yale Podnos?
Yale Podnos is a corporate insider, tracked as Chief Medical Officer of Starling Oncology, Inc. (STLN). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Yale Podnos last file a Form 4?
The most recent primary Form 4 on record is dated 17 July 2026, one of 9 filings going back to 2024.
Has Yale Podnos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($276K) across all tracked filings.
